AIM
NARI

Aigen Investment Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Aigen Investment Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,784
Closed -$397K – 1093
2024
Q4 		$397K Sell
7,784
-2,585
-25% -$127K 0.07% 399
2024
Q3 		$428K Buy
+10,369
New +$498K 0.08% 365
2023
Q3 		– Sell
-9,905
Closed -$576K – 1128
2023
Q2 		$576K Buy
+9,905
New +$625K 0.09% 315
2023
Q1 		– Sell
-21,413
Closed -$1.36M – 865
2022
Q4 		$1.36M Buy
21,413
+9,206
+75% +$668K 0.19% 140
2022
Q3 		$887K Buy
+12,207
New +$909K 0.13% 211
2021
Q4 		– Sell
-3,321
Closed -$269K – 1209
2021
Q3 		$269K Buy
+3,321
New +$279K 0.05% 363

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Aigen Investment Management's NARI Position: Q1 2025 in Review

Aigen Investment Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 7,784 shares — an estimated $397K sold.

Aigen Investment Management first reported a position in NARI in Q3 2021 and held it in 6 quarters. The position peaked at $1.36M in Q4 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Aigen Investment Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Aigen Investment Management sold 7,784 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $397K.
  • Aigen Investment Management first reported a position in Inari Medical, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • Aigen Investment Management's Inari Medical, Inc. Common Stock position peaked at $1.36M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Aigen Investment Management's 13F filing for Q1 2025, filed 12 May 2025.